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Abstract
Background: The Inborn Errors of Metabolism (IEM) are far from the rare systemic diseases that
mainly affect the neural tissue. There are very few written reports on ocular findings in subjects
with IEM, thus it was interesting to study the frequency of ocular findings in the studied population
and explore their contribution to the early diagnosis of IEM.
Methods: Our study involved the evaluation of IEM suspected cases, which had been identified in
a rural population in Crete, Greece. Over a period of 3 years, 125 patients, who fulfilled the
inclusion criteria of this study, were examined. Analytical physical examination, detailed laboratory
investigation as well as a thorough ocular examination were made.
Results: A diagnosis of IEM was established in 23 of the 125 patients (18.4%). Ten (43.5%) of the
diagnosed IEM had ocular findings, while 8 of them (34.8%) had findings which were specific for the
diagnosed diseases. One patient diagnosed with glycogenosis type 1b presented a rare finding. Of
the 102 non-diagnosed patients, 53 (51.96 %) presented various ophthalmic findings, some of which
could be related to a metabolic disease and therefore may be very helpful in the future.
Conclusions: The ocular investigation can be extremely useful for raising the suspicion and the
establishment of an early diagnosis of IEM. It could also add new findings related to these diseases.
The early management of the ocular symptoms can improve the quality of life to these patients.
Background
Until a few years ago, metabolic diseases, were thought to
be controversial entities with exotic names, only a few
people were involved in their research. The fact that the
majority of these diseases were considered incurable re-
duced the interest of their investigation. However, recent-
ly the situation has changed dramatically and metabolic
diseases have received serious attention and considerable
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progress has been made in prevention and therapeutic
management. It is now clear that metabolic diseases are
far from rare. The incidence of metabolic diseases in
North America and in Central and Northern Europe is
1:5000.
Metabolic diseases mainly affect the neural tissue, but
may also affect others such as the heart, liver, kidneys,
blood and eyes. The ocular symptoms and signs are found
in a large number of these diseases [4]. They frequently
represent an already allocated symptom of a systemic dis-
order. The ocular finding can rarely be so characteristic as
to render itself the key to the diagnosis, as for example in
Wilson's disease [5,6].
A pilot study has been implemented in rural Crete and its
first results and experiences have been reported in a recent
publication [7]. There are very few written reports on ocu-
lar findings in subjects with inborn errors of metabolism
(IEM), thus it was interesting to study the frequency of oc-
ular findings in the studied population and explore their
contribution to the early diagnosis of IEM.
Methods
Our pilot study was carried out during the period from
January of 1997 to January 2000. The predominant source
of the study's data was derived from the eight Primary
Health Care Centres in rural Crete, which accounts for
225,000 inhabitants, and are taking part in the activities
of the Cretan Primary Healthcare Network [7]. An invita-
tion was extended to all of the primary care physicians of
these Health Centres, of which eight medical doctors par-
ticipated in an intensive educational programme for IEM
and their early diagnosis. A checklist with specific illness
conditions, symptoms and clinical signs was drawn up
(see additional file 1). Primary care physicians checked
the presence of at least one condition, sign or symptom in
all children or adults who visited the participating Health
Centres and who had been symptomatic since childhood
and were not related to other conditions. They referred all
eligible subjects to the Department of Child Care at the
University Hospital of Heraklion, Crete. Three of children
who had examined at the Department of Ophthalmology
at the University Hospital of Heraklion had fulfilled the
inclusion criteria were added in our study sample. A full
and analytical physical examination as well as a detailed
laboratory investigation was made in this department. Pa-
tients with history of perinatal asphyxia, infection, injury
or tumor of the central nervous system were excluded of
the study. An ophthalmologic evaluation was part of this
assessment. The ophthalmologic evaluation included the
following:
(1) Case History (Personal and Family). (2) Visual acuity
measurements for near and/or distant vision. In selecting
the method of estimation of visual acuity we took into
consideration factors such as age, existence of mental re-
tardation, and collaboration of the patient. (3) Color Per-
ception (using the Ishihara Isochromatic Cards). (4) Pupil
reflexes (direct and indirect). (5) Near reflex. (6) Orthop-
tic evaluation including conjugate eye movements; cover-
uncover test; cover-test and prism cover test where it was
necessary. (7) Examination for presence of nystagmus. (8)
Slit lamp examination of the anterior segment of the eye.
(9) Retinoscopy. (10) Indirect ophthalmoscopy. (11)
Photography when applicable.
The ocular investigation was performed every year on each
patient included in the study.
Results
During the 3-year period the study involved the examina-
tion of 125 subjects which fulfilled the inclusion criteria
of this study. There were 75 males (60%) and 50 females
(40%). The ages were between 0 to 30 years. The mean age
of the examined patients was 6.34 (S.D: ± 5.75) years. Of
the 125 subjects examined, a diagnosis of IEM was estab-
lished in 23 (18.4%). Subsequently 63 (50.4%) had ocu-
lar findings.
From the 23 diagnosed patients, 10 (43.5%) had ocular
findings, and 8 of these (34.8%) had findings specific for
the diagnosed diseases (see additional file 2). In one pa-
tient diagnosed with glycogenosis type 1b a rare finding of
large preretinal spherical deposits near the ora serrata was
documented. These deposits probably consisted of glyco-
gen and/or triglycerides. To the best of our knowledge,
this finding has not previously been reported in any pub-
lication.
Thirteen (56.5%) of the diagnosed patients had no ocular
findings (5 patients with organic acidurias, 2 with glycog-
enosis type la, 2 b-oxidation defects, one with lysosomal
disorder, one mitochondriopathy and two with aminoac-
id disorders).
From the 102 non-diagnosed patients 40 (39.21%) had
no ocular findings and 9 (8.82%) had only a very low re-
fractive error (-2.0D to + 2.0D). Fifty – three (51.96 %)
undiagnosed patients presented various ophthalmic find-
ings that are shown in (see additional file 3)
Discussion
This study attempted to show the significance of the ocu-
lar investigation in the early diagnosis and management
of IEM. It is known that IEM affect vision because of the
damage to the brain, visual pathways and other eye struc-
tures such as the lens, the cornea and the retina. The exist-
ence of the ocular finding was critical for the suspicion of
the disease and the definitive diagnosis in several of theBMC Ophthalmology 2002, 2 http://www.biomedcentral.com/1471-2415/2/2
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diagnosed patients (18.4%). Of the 23 diagnosed pa-
tients, 10 (43, 47%) presented ocular symptoms (Table 2).
In 4 patients (with Canavan's disease, metachromatic leu-
codysrtophy and adrenoleucodystrophy) the suspicion of
the disease was set because of the other clinical symptoms
in spite of the fact that atrophy of the optic nerve was a
specific finding [8]. In 8 (34,78%) of the 10 diagnosed pa-
tients the ocular symptoms were specific for the underly-
ing disease. This means that 80% (8/10) of the patients
diagnosed with ocular symptoms had specific ocular find-
ings for the diagnosed disease.
The diagnosis of IEM represents one of the most difficult
aspects of medicine and their differential diagnosis from
perinatal lesions is not always easy. In this case, the ocular
findings can be of great value in directing the diagnosis to
a specific disease. This was the case with one of our pa-
tients with Niemman-Pick type C who had a very slow
progression. It was the ocular findings (vertical gaze pare-
sis, doll's eye movements and retinitis pigmentosa) which
led to the suspicion of the diagnosis [9,11].
In the cases of the patients with Kearns-Sayre syndrome,
mannosidosis and Lowe's syndrome the ocular findings
were characteristic for the disease and contributed to the
fast diagnosis of the underlying disease. The patient with
the Kearns-Sayre syndrome exhibited the typical triad of
progressive external ophthalmoplegia, retinal pigmentary
degeneration, and heart block [12,14]. The patient with
Mannosidosis presented a progressively developing
wheel-like cataract and optic disk pallor [15,16] which
was probably related to demyelination and associated
gliosis involving the parieto-occipital white matter [17].
The patients mother was at the first trimester of her 2nd
pregnancy. Prenatal screening was ordered which revealed
the some diagnosis in the fetus [18]. The patient in Lowe's
syndrome (oculocerebrorenal syndrome) presented con-
genital discoid cataracts [19,20], miosis, congenital glau-
coma [21]. The mother had flake like opacities of the
lenses, a typical finding in a female carrier [22]. The child
was treated for cataracts, and glaucoma. Currently, he is
under topical therapy with a b-blocker.
In biotinidase deficiency, strabismus is a non-specific oc-
ular finding. However, it is described in 30% of the pa-
tients in various research studies [23,24].
The case of a patient with glycogenosis type 1b is of inter-
est. This patient presented large preretinal spherical de-
posits near the ora serrata, probably consisting of
glycogen and/or triglycerides. This patient was under no
therapeutic scheme until the age of 25. Three years later in
a new fundus examination the large preretinal deposits
were absorbed and replaced with small drussen-like pre-
retinal deposits. These new deposits were mainly concen-
trated in the peripheral retina of the inferior nasal
quadrant of each eye. Our ocular finding in glycogenosis
type 1b may be correlated with ocular findings reported
by other authors for this disease. [25].
It is an interesting fact that although 18.4% were finally
diagnosed, but ocular findings existed in 50.4% of them.
The findings in undiagnosed patients were notable. A
high percentage of ocular findings were documented for
these patients (51.96%) A tight surveillance of the undiag-
nosed patients is important as some of these findings may
be related to a metabolic disease, the existence of which
can not be established at the present time although it is
certain that some of these findings should be very helpful
in the future.
The high percentage of ocular findings (43.47% in the di-
agnosed and 51.96% in the undiagnosed patients) in
both diagnosed and undiagnosed patients is indicative of
the significant involvement of the eye in problems raising
a suspicion of an IEM disease. The ocular evaluation of
these patients seems to be obligatory.
Conclusions
The results of this study demonstrate that a thorough oph-
thalmologic examination can be extremely useful for the
pediatricians and the neurologist concerning the diagno-
sis of metabolic neurogenetic diseases. For the establish-
ment of the diagnosis, the collaboration of various
institutes is usually necessary in some cases the diagnosis
can be facilitated by the ophthalmologic findings. Moreo-
ver, there are cases where an ophthalmologic examination
is the main examination that leads to the early recognition
of these diseases. Finally, the amelioration of the ocular
symptoms can offer a better quality of life to those pa-
tients.
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